Textual Amendments
F1Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)
49.—(1) Subject to sub-paragraph (2), any person—
(a)who—
(i)holds a traditional herbal registration immediately before IP completion day which remains in force on IP completion day (whether or not it is suspended),
(ii)has made an application for, or to renew, a traditional herbal registration before IP completion day, which has not been determined by the licensing authority before that date, or
(iii)makes such an application on or after IP completion day but before the end of the transitional period; and
(b)who was, immediately before IP completion day, established in an EEA State and who remains there on and after that day,
is to be treated, for the transitional period, as satisfying the requirements of regulation 127(3) or 133(2) (as the case may be), notwithstanding the amendments made to those provisions by the EU Exit Regulations.
(2) But sub-paragraph (1) continues to apply to a person, only in relation to a registration in force in Great Britain, and only if the person notifies the licensing authority in writing of—
(a)a named individual who resides and operates in the United Kingdom who the licensing authority may contact in respect of any matter relating to the traditional herbal registration, or application for a traditional herbal registration, during the transitional period; and
(b)that individual's address, telephone number and email address.
(3) A person must notify the licensing authority under sub-paragraph (2)—
(a)where sub-paragraph (1)(a)(i) or (ii) applies, within the period of 4 weeks beginning with IP completion day; or
(b)where sub-paragraph (1)(a)(iii) applies, at the time of making the application.
(4) In this paragraph “the transitional period” means the period of 24 months beginning with IP completion day.
50.—(1) Subject to sub-paragraph (2), a person to whom paragraph 49 applies does not commit an offence under regulation 268 (offence relating to packaging and package leaflets in Great Britain) during the transitional period in relation to a product to the extent that—
(a)the packaging and package leaflet do not comply with the requirements of Part 13 (packaging and leaflets) by reason only of the fact that the outer or immediate packaging, or the package leaflet (as the case may be), do not include the correct information as to—
(i)the name and address of the holder of the traditional herbal registration, or, if applicable, the holder's representative,
(ii)the number of the traditional herbal registration, or
(iii)the name and address of the manufacturer of the product; and
(b)the outer and immediate packaging, or the package leaflet, do not include the correct information specified in paragraph (a)(i) to (iii) solely because—
(i)the holder of the traditional herbal registration has established itself in the United Kingdom before the end of the period of 24 months beginning with IP completion day in order to comply with regulation 127(3) or 133(2), and
(ii)the information specified in paragraph (a)(i) to (iii) is no longer correct as a consequence of that establishment in the United Kingdom.
(2) Sub-paragraph (1) only applies if—
(a)the packaging and package leaflet met the requirements of Part 13 as to the matters specified in sub-paragraph (1)(a)(i) to (iii) immediately before IP completion day; and
(b)the holder of the traditional herbal registration, having established itself in the United Kingdom, does not otherwise need to make any changes to the outer or immediate packaging, or the package leaflet, as the case may be, during the transitional period.
(3) In this paragraph “the transitional period” means the period of 36 months beginning with IP completion day.
51.—(1) For the purpose of regulation 125A (list of approved countries for traditional use of a herbal medicinal product), the licensing authority must, for the transitional period, include each EEA State in the list it publishes under regulation 125A(1).
(2) The licensing authority must not, before the end of the transitional period, exercise its power under regulation 125A(3) to remove an EEA State from the list.
(3) In this paragraph, the transitional period is two years beginning with IP completion day.
52.—(1) Sub-paragraph (2) applies where an application for a traditional herbal registration to be in force in Great Britain only has been made before IP completion day and—
(a)regulation 130(12) and (13) (applications to be determined under Chapter 4 of Title III of the 2001 Directive) applied to that application before IP completion day; but
(b)a decision as specified in Article 28(5) of the 2001 Directive has not been adopted by the licensing authority before IP completion day.
(2) Where this sub-paragraph applies, the licensing authority must—
(a)where the procedure specified in Article 28(4) of the 2001 Directive has concluded before IP completion day in relation to that application, grant a traditional herbal registration in respect of that application as soon as reasonably practicable, and in any event before the end of the period of 30 days, beginning with IP completion day; or
(b)where the procedure specified in Article 28(4) of the 2001 Directive has not concluded before IP completion day, determine that application in accordance with Part 7 of these Regulations as soon as reasonably practicable, unless the applicant notifies the licensing authority in writing that they no longer want the application to proceed.
(3) In making a determination under sub-paragraph (2)(b), the licensing authority must have regard to—
(a)any relevant information obtained by it before IP completion day in relation to the application as a consequence of its involvement in any procedure provided for in Chapter 4 of Title III of the 2001 Directive;
(b)any relevant decision made, or agreement reached, before IP completion day, where the United Kingdom participated as a reference member state or concerned member state in the making of that decision or agreement, under any procedure provided for in Chapter 4 of Title III of the 2001 Directive;
(c)any advice it receives from the appropriate committee pursuant to the procedures in Schedule 11 (advice and representations).
(4) In making a determination under sub-paragraph (2)(b), the licensing authority must take all reasonable steps to ensure that it makes a decision to grant or refuse a traditional herbal registration in the time period specified in regulation 130(1) as if it had applied to that application on the date on which the application was submitted.
53. Where, immediately before IP completion day, a traditional herbal registration in force in Great Britain only has been suspended pursuant to the procedures in Chapter IV of Title III of 2001 Directive, the suspension—
(a)continues to have effect on and after IP completion day in accordance with the terms on which it was imposed; and
(b)is to be treated as if it had been imposed by the licensing authority under Part 7 of these Regulations (traditional herbal registrations).
54.—(1) Sub-paragraph (2) applies where—
(a)a specified matter has been referred under Article 31 of the 2001 Directive before IP completion day; but
(b)the procedure has not concluded before IP completion day.
(2) Where this sub-paragraph applies, the licensing authority must make a decision in respect of the specified matter in accordance with regulation 135 (revocation, variation and suspension of traditional herbal registration) as soon as reasonably practicable.
(3) In making a decision under regulation 135 in accordance with sub-paragraph (2), the licensing authority must have regard to—
(a)any relevant information obtained by it before IP completion day in relation to the specified matter as a consequence of its involvement in any procedure provided for in Chapter 4 of Title III of the 2001 Directive;
(b)any relevant decision made, or agreement reached, before IP completion day, where the United Kingdom participated as a member state in the making of that decision or agreement, under any procedure provided for in Chapter 4 of Title III of the 2001 Directive;
(c)any advice it receives from the appropriate committee pursuant to the procedures in Schedule 11 (advice and representations).
(4) Sub-paragraph (5) applies if the licensing authority is making a decision under regulation 135 of these Regulations in accordance with sub-paragraph (2) in a case where the Co-ordination Group for Mutual Recognition and Decentralised procedures has given an opinion in relation to the matter under Article 31 of the Directive.
(5) Where this sub-paragraph applies, the licensing authority may treat the opinion as if it were the opinion of the appropriate committee for the purposes of paragraph 5 of Schedule 11.
(6) Sub-paragraph (7) applies where—
(a)a specified matter has been referred under Article 31 of the 2001 Directive before IP completion day;
(b)the referral has concluded before IP completion day; but
(c)the licensing authority has not, before IP completion day, taken the steps necessary to give effect to that decision or that opinion (as the case may be).
(7) Where this sub-paragraph applies, the licensing authority must take the steps necessary as a result of the decision or opinion to suspend, revoke or vary the traditional herbal registration within the time period specified in Article 34(3) of the 2001 Directive where the decision or opinion requires steps to be taken in relation to a traditional herbal registration.
(8) In this paragraph—
“concluded before IP completion day”, in relation to an Article 31 referral, means—
a Commission decision as provided for in Article 34(3) of the 2001 Directive has been taken before IP completion day; or
an opinion of the Co-ordination Group for Mutual Recognition and Decentralised Procedures, which constituted the end of the Article 31 referral procedure, has been given before IP completion day; and
“specified matter” means—
a matter referred under Article 31 of the 2001 Directive before IP completion day that concerns a proposal to suspend, revoke or otherwise vary a traditional herbal registration; but
does not include a referral made under Article 107i of the 2001 Directive.
55.—(1) This paragraph applies where—
(a)the licensing authority has proposed to refer an application for a traditional herbal registration to be in force in Great Britain only to the Committee on Herbal Medicinal Products in accordance with Article 16c(4) of the 2001 Directive before IP completion day; but
(b)that application has not been determined in accordance with Part 7 of these Regulations before IP completion day.
(2) Where the licensing authority has received an opinion of the Committee for Herbal Medicinal Products before IP completion day in relation to the application, it must take that decision in to account and determine that application.
(3) Where the licensing authority has not received an opinion of the Committee for Herbal Medicinal Products before IP completion day, notwithstanding the amendments made to Part 3 of Schedule 11 by the EU Exit Regulations, it may—
(a)proceed to determine the application, taking into account any proceedings that took place before IP completion day under Part 3 of Schedule 11 (prior to its amendment by the EU Exit Regulations), or any opinion of the Committee on Herbal Medicinal Products in relation to the application that is given on or after IP completion day; or
(b)it may refer the matter under regulation 130A in order to obtain the findings and advice of the appropriate committee before determining the application.]